nasal

A simple nasal spray significantly reduced snoring and breathing difficulties in children and halved the number needing to have their tonsils removed, according to a new study. The research, led by the Murdoch Children's Research Institute…

The emergence of a new, ‘highly infectious’ Covid variant — responsible for more than 40 per cent of cases in the U.S., where hospitalisations reached more than 40,000 a day in December — is a grim reminder that the pandemic is far from…

As the COVID-19 pandemic showed, potentially dangerous new viruses can begin to spread in the population well before the global public health surveillance system can detect them. However, Yale researchers have found that testing for the…

iNCOVACC, the intra-nasal vaccine developed by Bharat Biotech International Limited. ANI…

Last Updated: December 27, 2022, 18:09 ISTBefore you make your toddler have medicines, you must try some home remedies first.It might be easier for your child to cough up mucus if it is thinned out by water or other fluids. A blocked…

The union government has approved Bharat Biotech's intranasal vaccine, iNCOVACC. It will be used as a heterologous booster & will be available first in private hospitals. It will be included in COVID vaccination program from today,…

Last Updated: December 02, 2022, 22:53 ISTThe nasal sprays are a part of a line of drugs that scientists want to develop to prevent the virus from entering the body (Representational Image)The nasal sprays are a part of a line of drugs that…

Naloxone, packaged with instructions, is one of the items given out by the Baltimore Harm Reduction Coalition outreach workers.Amy Davis | Baltimore Sun | Getty ImagesThe Food and Drug Administration on Tuesday indicated it might approve…

A Yale-designed nasal vaccine can help bolster immune responses to COVID-19 in previously vaccinated animals and reduce viral transmission, Yale researchers report Oct. 27 in the journal Science. The new vaccine approach developed by Yale…

Attempts by Oxford University researchers and AstraZeneca Plc to create a nasal-spray version of their jointly developed COVID-19 shot suffered a setback on Tuesday (Oct 11) as initial testing on humans did not yield the desired protection.…